AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Preventing neural graft rejection in Parkinson's patients

Researchers have engineered a way to fool the immune system into accepting neural grafts as part...

Retinal health linked to dementia risk, study shows

Researchers have discovered that the blood vessels at the back of the eye — called retinal...

Pancreatic cancer hijacks metabolism switch to help it spread

Pancreatic cancer hijacks a molecule known for regulating physiological processes, such as food...

Content from other channels on our network

Adapting to the future of poultry farming in Australia

Spreading Success: How Pic's Went Global with Fishbowl

IAL sets new standard in food production with Rittal Hygienic Design Enclosures

Advanced Manufacturing for local industry

Transform your food processing operations with the PlantPAx distributed control system

Council improves Hat Head sewage treatment plant with Gorman-Rupp wastewater pumps

ARRC to represent Australia at the ReMA 2025 event

Senate inquiry sees strong future for tyre recycling

Samsara Eco to build new plastics recycling plant

Opal partners with BlockTexx to reduce uniform waste

Supporting Nurses this International Nurses Day… and Every Day

Smarter, Safer, Cleaner: The Future of Hospital Floor Care is Robotics

Protecting Patient Health

Hep C point-of-care test helps marginalised populations

Residential eating disorder treatment centre is a Victorian first